An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
Overview
- Phase
- N/A
- Intervention
- Inpatient serious illness care program
- Conditions
- Hematologic Malignancies
- Sponsor
- University of Rochester
- Enrollment
- 41
- Locations
- 1
- Primary Endpoint
- Retention Rate
- Status
- Completed
- Last Updated
- 2 months ago
Overview
Brief Summary
This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
Detailed Description
Older adults with hematologic malignancies receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness conversations for patients with hematologic malignancies, leading to less aggressive healthcare utilization at the end of life. This pilot aims to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies.
Investigators
Kah Poh Loh
Associate Professor - Department of Medicine, Hematology/Oncology (SMD)
University of Rochester
Eligibility Criteria
Inclusion Criteria
- •Age ≥60 years
- •A diagnosis of hematologic malignancy \[including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment\]
- •Able to provide informed consent
- •Being managed in the inpatient setting
- •English-speaking
Exclusion Criteria
- Not provided
Arms & Interventions
Experimental
Patients will participate in an inpatient advance care planning intervention.
Intervention: Inpatient serious illness care program
Outcomes
Primary Outcomes
Retention Rate
Time Frame: From consent until completion of the ACP intervention visit, usually within 1 week.
Retention rate is the percentage of consented patients who completed the ACP intervention visit. A retention rate of \>70% was considered feasible.
Secondary Outcomes
- Advance Directive Completion - HCP(From baseline (pre-intervention) to 1 year post-intervention. The time interval is approximately 1 year.)
- Advance Directive Completion - MOLST(From baseline (pre-intervention) to 1 year post-intervention. The time interval is approximately 1 year.)